SPECTRAL MEDICAL INC (EDT.CA) Stock Analyst Earnings Estimates
TSX:EDT - Toronto Stock Exchange - CA8475771033 - Common Stock - Currency: CAD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.05M -2.38% | 1.67M -18.54% | 1.598M -4.31% | 2.121M 32.73% | 2.424M 14.29% | |
| EBITDA YoY % growth | -8.3M 5.47% | -8.17M 1.57% | -11.518M -40.98% | -10.1M 12.31% | -4.848M 52.00% | |
| EBIT YoY % growth | -8.6M 5.39% | -8.45M 1.74% | -11.736M -38.89% | -8.282M 29.43% | N/A | |
| Operating Margin | -419.51% | -505.99% | -734.42% | -390.48% | N/A | |
| EPS YoY % growth | -0.04 20.45% | -0.04 -14.29% | -0.06 -42.70% | -0.07 -23.87% | -0.03 57.14% |
All data in CAD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in CAD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2024 Q2Q % growth | -0.01 -37.46% | % | ||
| Q1 2024 Q2Q % growth | -0.01 -36.79% | % | ||
| Q4 2023 Q2Q % growth | -0.03 -286.83% | -0.01 | -0.02 | -168.10% |
| Q3 2023 Q2Q % growth | -0.01 16.67% | -0.01 | 0.00 | 0.99% |
| Q2 2023 Q2Q % growth | -0.01 9.09% | -0.01 | 0.00 | 0.99% |
| Q1 2023 Q2Q % growth | -0.01 | -0.01 | 0.00 | 0.99% |
| Q4 2022 Q2Q % growth | -0.01 30.00% | -0.01 | 0.00 | 30.69% |
| Q3 2022 Q2Q % growth | -0.01 -50.00% | -0.01 | 0.00 | -18.81% |
| Q2 2022 Q2Q % growth | -0.01 -10.00% | -0.01 | 0.00 | -8.91% |
| Q1 2022 Q2Q % growth | -0.01 -42.86% | -0.01 | 0.00 | 0.99% |
| Q4 2021 Q2Q % growth | -0.01 | -0.01 | 0.00 | 0.99% |
| Q3 2021 Q2Q % growth | -0.01 20.00% | -0.01 | 0.00 | 20.79% |
| Q2 2021 Q2Q % growth | -0.01 -11.11% | -0.01 | 0.00 | 0.99% |
| Q1 2021 Q2Q % growth | -0.01 53.33% | -0.01 | 0.00 | 30.69% |
| Q4 2020 Q2Q % growth | -0.01 -66.67% | -0.01 | 0.00 | 0.99% |
| Q3 2020 Q2Q % growth | -0.01 | -0.01 | 0.00 | 0.99% |
| Q1 2020 Q2Q % growth | -0.02 | 0.01 | -0.03 | -248.51% |
| Q4 2019 Q2Q % growth | -0.01 | -0.01 | 0.00 | 40.59% |
| Q3 2019 Q2Q % growth | -0.01 | -0.01 | 0.00 | 0.99% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 502K 26.45% | % | ||
| Q2 2024 Q2Q % growth | 467.364K 52.73% | % | ||
| Q1 2024 Q2Q % growth | 683.95K 29.05% | % | ||
| Q4 2023 Q2Q % growth | 365.553K -29.70% | 707K | -341.447K | -48.30% |
| Q3 2023 Q2Q % growth | 397K 7.30% | 303K | 94K | 31.02% |
| Q2 2023 Q2Q % growth | 306K 5.52% | 303K | 3K | 0.99% |
| Q1 2023 Q2Q % growth | 530K 10.42% | 404K | 126K | 31.19% |
| Q4 2022 Q2Q % growth | 520K | 404K | 116K | 28.71% |
| Q3 2022 Q2Q % growth | 370K 60.87% | 404K | -34K | -8.42% |
| Q2 2022 Q2Q % growth | 290K -48.21% | 606K | -316K | -52.15% |
| Q1 2022 Q2Q % growth | 480K -36.00% | 606K | -126K | -20.79% |
| Q4 2021 Q2Q % growth | 520K -3.70% | 505K | 15K | 2.97% |
| Q3 2021 Q2Q % growth | 230K -45.24% | 606K | -376K | -62.05% |
| Q2 2021 Q2Q % growth | 560K 7.69% | 505K | 55K | 10.89% |
| Q1 2021 Q2Q % growth | 750K 19.05% | 606K | 144K | 23.76% |
| Q4 2020 Q2Q % growth | 540K -28.00% | 505K | 35K | 6.93% |
| Q3 2020 Q2Q % growth | 420K -20.75% | 606K | -186K | -30.69% |
| Q2 2020 Q2Q % growth | 520K -50.00% | 1.414M | -894K | -63.22% |
| Q1 2020 Q2Q % growth | 630K 14.55% | 6.969M | -6.339M | -90.96% |
| Q4 2019 Q2Q % growth | 750K | 808K | -58K | -7.18% |
| Q3 2019 Q2Q % growth | 530K | 808K | -278K | -34.41% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | -40% |
| Revenue | N/A | N/A | 0% | 40% |